FDA Warning Letter - Critical cGMP Failures at Granules India Ltd | Key Learnings for Professionals
In this video, we analyze the FDA warning letter issued to Granules India Limited on February 26, 2025, highlighting serious CGMP violations including cleaning failures, poor facility maintenance, equipment issues, and data integrity breaches. 👉 Whether you're a QA professional, regulatory affairs specialist, or a pharma student—this breakdown provides actionable insights into: Why proper cleaning validation is essential How inadequate HVAC systems can cause contamination What poor data practices mean for compliance What FDA expects in your CAPA responses 🎯 Learn from this real-world case study and strengthen your pharmaceutical manufacturing and quality systems to stay GMP-compliant and audit-ready. 📌 Don’t forget to subscribe to PharmaGuideline for weekly videos on GMP, audits, validation, and FDA inspections. #FDAWarningLetter #PharmaCompliance #GMPFailures #PharmaQuality #GranulesIndia #CGMP #FDAInspection #PharmaTraining #DataIntegrity #CleaningValidation #PharmaGuideline Boost Your Pharma Knowledge with Our Exclusive Courses! 🚀📚 Explore our in-depth courses designed for pharmaceutical professionals and students. Gain industry-relevant skills, stay compliant with regulations, and advance your career with expert-led training. 📌 Featured Courses:    • CAPA Management Course     • Analytical Method Validation Course     • GMP Course  💡 Join our Membership to get exclusive access to premium content, industry insights, and priority support!    / @pharmaguideline  To Get a Certificate Enroll on our website - https://courses.pharmaguideline.com 📢 Stay ahead in the pharma industry—subscribe to our channel for regular updates! #PharmaceuticalCourses #GMPTraining #CAPA #MethodValidation #PharmaCareers #QualityAssurance #regulatorycompliance Related Topics: FDA warning letter 2025 Granules India warning letter GMP violations India CGMP non-compliance FDA inspection findings cleaning validation HVAC in pharma data integrity pharma pharmaceutical QA pharma compliance training pharma regulatory quality assurance pharma GMP case study CAPA pharmaceutical FDA audit failures FDA 483 explanation pharma industry India pharma manufacturing GMP warning letter case study pharma quality systems
Understanding 21 CFR in Pharmaceuticals | Full Breakdown for Compliance Professionals
8 Common Regulatory Compliance Mistakes in Pharmaceuticals | How to Avoid Common Compliance Mistakes
Glenmark Warning Letter July 2025 | USFDA Warning Letters
Top 10 FDA 483 Observations | Avoid Common GMP Violations in Pharma | Pharmalytics
Cleaning Validation in Pharma | Basics, Guidelines & Examples
Understanding Data Integrity Part IV: FDA Warning Letter Examples and Q&A
How To Think SO Clearly People Assume You're Brilliant
Understanding the US FDA Drug Approval Process | Step-by-Step Explanation for Pharma Professionals
How to Manage Unannounced FDA Inspections I How to Handle Surprise FDA Inspections
Discover Aseptic Fill-Finish – A Critical Step in Parenteral Manufacturing
Understanding FDA Form 483: What You Need to Know! #FDA Inspection #483 #form483 #FDA #fda483
Billionaire's WARNING: I'm SELLING. The Crash Is Already Here!
If You Have A Bad Memory, I’ll Help You Fix It In 28 Minutes
FDA's Latest Guidelines for Pharma Manufacturing | What's New?
The Mitochondria Doctor: This Reverses Gray Hair, Makes You Feel Young Again & Fixes Disease!
What is a FDA Warning Letter and how to respond #gmpguide | Free GMP Training Course 2025
FDA Form 483 and Warning Letter – The Basics & the Differences
ICH Guidelines Explained | A Complete Overview for Pharmaceutical Professionals
FDA form 483 and Warning Letter| What is the difference?
